Tunesi, S., Dû, D. L., Gualano, G., Millet, J., Skrahin, A., Bothamley, G., Casas, X., Goletti, D., Lange, C., Musso, M., Palmieri, F., Pourcher, V., Rioux, C., Skrahina, A., Veziris, N., Viatushka, D., Jachym-Fréchet, M., Guglielmetti, L., , , Marigot-Outtandy, D., Lescure, X., Dubert, M., Yazdanpanah, Y., Caumes, E., Choinier, P., Haddad, E., Kowalczyk, J., Laurichesse, H., Lesens, O., Aubry, A., Bonnet, I., & Morel, F. (2022). co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study. Journal of infection, 84(6), 834–872. http://access.bl.uk/ark:/81055/vdc_100155154348.0x00004d